Timing and Impact of Decisions to Adjust Disease-Modifying Antirheumatic Drug Therapy for Rheumatoid Arthritis Patients With Active Disease.

Yomei ShawChung-Chou H ChangMarc C LevesqueJulie M DonohueKaleb D MichaudMark S Roberts

Published in: Arthritis care & research (2018)

Adjusting DMARDs within 90 days was associated with shorter times to LDAS, but many patients with persistent MHDAS waited >90 days to adjust DMARDs. Interventions are needed to address the timeliness of DMARD adjustments for RA patients with MHDAS.

Keyphrases

rheumatoid arthritis
rheumatoid arthritis patients
disease activity
systemic lupus erythematosus
ankylosing spondylitis
interstitial lung disease
physical activity
adverse drug